Expanding Horizons: Bullish Buy Rating as Greenwich LifeSciences's Breast Cancer Trial Goes Pan-European
TipRanksFeb 28 19:27
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36
BenzingaFeb 20 20:47
Greenwich LifeSciences Analyst Ratings
BenzingaFeb 20 20:46
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), BioMarin Pharmaceutical (BMRN) and Greenwich LifeSciences (GLSI)
TipRanksFeb 20 19:30
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38
BenzingaApr 11, 2023 00:10
H.C. Wainwright Sticks to Its Buy Rating for Greenwich LifeSciences (GLSI)
TipRanksApr 11, 2023 00:06
Analysts Conflicted on These Healthcare Names: Nabriva (NBRV), Vir Biotechnology (VIR) and Greenwich LifeSciences (GLSI)
TipRanksNov 29, 2022 20:35
No Data
No Data